ToeFX selected for the OBIO-CAAP 2021 cohort

We are excited at being selected to be in this year’s cohort of 2021 Capital Access Advisory Program from The Ontario Bioscience Innovation Organization.

Proud to be recognized as a high potential health science company and looking forward to continuing the momentum with many more innovative solutions. The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2021 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s cohort.